- $8.85bn
- $9.31bn
- $1.97bn
- 84
- 37
- 57
- 62
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 20-F | 20-F | 20-F | 20-F | 20-F |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,526 | 1,870 | 2,252 | 2,142 | 1,965 |
Cost of Revenue | |||||
Gross Profit | 1,005 | 1,233 | 1,451 | 1,385 | 1,234 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,548 | 1,484 | 1,622 | 1,610 | 1,560 |
Operating Profit | -21.3 | 386 | 630 | 531 | 406 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -77.8 | 439 | 626 | 513 | 430 |
Provision for Income Taxes | |||||
Net Income After Taxes | -41.5 | 359 | 513 | 423 | 341 |
Net Income Before Extraordinary Items | |||||
Net Income | -41.5 | 359 | 513 | 423 | 341 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -41.5 | 359 | 513 | 423 | 341 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.798 | 2.07 | 2.38 | 2.06 | 1.67 |